Related Experiment Video
Updated: Jul 6, 2026
10:40
Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
Adiponectin and leptin in relation to insulin sensitivity
1Clinical Research Center, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Metabolic Syndrome and Related Disorders
|March 29, 2008
Summary
Obesity and central fat distribution are linked to insulin resistance and cardiovascular diseases. Adipose tissue is an active organ producing adipocytokines, crucial for understanding metabolic health.
Area of Science:
- Metabolic Physiology
- Endocrinology
- Obesity Research
Background:
- Adipose tissue, once considered a passive lipid storage site, is now recognized as a vital endocrine organ.
- Increased adipose tissue and central obesity are associated with metabolic disorders like insulin resistance, type 2 diabetes, dyslipidemia, and atherosclerosis.
- Adipose tissue secretes various adipocytokines, including adiponectin and leptin, which mediate crucial metabolic functions.
Purpose of the Study:
- To review the metabolic roles of adiponectin and leptin.
- To elucidate the connection between these adipocytokines, obesity, and insulin sensitivity.
Main Methods:
- Literature review of current research on adipocytokines.
- Focus on the physiological functions of adiponectin and leptin.
- Analysis of their impact on insulin sensitivity and endothelial function.
Main Results:
- Adiponectin and leptin are key adipocytokines influencing metabolic homeostasis.
- These proteins are implicated in the link between obesity, insulin resistance, and endothelial dysfunction.
- Understanding their roles is critical for metabolic disease research.
Conclusions:
- Adipose tissue plays a significant endocrine role in metabolic regulation.
- Adiponectin and leptin are central players in the pathophysiology of obesity-related metabolic dysfunction.
- Further research into adipocytokines may reveal therapeutic targets for metabolic diseases.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...